The latin america IVD market is expected to reach over USD 5.1 billion by 2024, according to a new report by Grand View Research, Inc. The Latin America IVD market is expected to grow at a significant CAGR till 2024 owing to the rising prevalence of target disorders, aging population, and the presence of favorable government initiatives for early disease diagnosis. Other factors that are anticipated to boost the growth include the introduction of technologically advanced instruments and the increasing R&D initiatives for the development of disease-specific kits.
Regular testing for diabetes, cardiovascular, cancer, and sexually transmitted diseases are necessary for the timely treatments, further avoiding the risk of fatal health complications. The availability of tests for home and near patient testing is estimated to further enhance the usage rates of these devices. From November 2015, the Anvisa, which is a regulatory body for medical devices in Brazil, has started allowing the registration for HIV self-testing kits.
Click for Report Details @ http://www.radiantinsights.com/research/latin-america-in-vitro-diagnostics-ivd-market
The increasing adoption point of care devices coupled with the increasing awareness among the healthcare professionals regarding the early diagnosis of various diseases has provided a boost to the Latin IVD market. The rising epidemic of communicable diseases in the southernpart of Latin America, the growing need for rapid and accurate diagnostics, and the changing healthcare infrastructure scenario are some of the key drivers of the Latin IVD market.
Further key findings from the study suggest:
The instrument segment is one of the most important segments of in vitro diagnostics. The presence of highly automated analyzers and the availability of over the counter products are some of the factors responsible for its significant share.
The Molecular diagnostics segment is anticipated to be the fastest growing technology over the decade. Molecular diagnostics is a transformative area of diagnostics. The continuous innovation in technology helps the physicians for critical decision making
The infectious disease segment held the largest share in 2015 over 24% owing to the presence of favorable government initiatives in association with the WHO to curb communicable diseases.
The home care segment is estimated to witness a significant growth over the forecast period. The high number of R&D initiatives undertaken by key competitors for the development of portable IVD devices with improved sensitivity and user-friendliness is a key factor attributing towards its growth.
In 2015, Brazil was the largest regional segment with a revenue generation of over USD 1.2 billion owing to the established healthcare infrastructure, growing awareness for cancer screening, and the increasing demand for genetic testing.
Peru is expected to be one of the fastest growing regions on account of the growing economic stability, high unmet clinical needs, and the rising disposable incomes
Key players operating in the Latin America IVD market are Roche Diagnostics, Abbott Laboratories, Inc., Hologic (Gen-Probe), Becton Dickinson (BD) Company, Alere, Inc., Bio-Rad Laboratories, Qiagen N.V., Inc., bioMerieux, BioQuidel Corporation, and Siemens Healthcare.
Related Reports by Radiant Insights:
Medical Digital Imaging Systems Market Analysis –
Medical X-ray Generator Market Analysis –
Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
2.1. Latin America IVD Market- Industry Snapshot and Key Buying Criteria, 2015
Chapter 3. Latin America IVD Industry Outlook
3.1. Latin America IVD Market Segmentation
3.2. Latin America IVD Market Size and Growth Outlook
3.3. Latin America IVD Market Dynamics
3.3.1. Market Drivers Estimates
126.96.36.199. Substantial Increase in Geriatric Population in Latin America
188.8.131.52. Considerable Prevalence of Chronic Disease
184.108.40.206. Growing Need for Point of Care Facilities.
3.3.2. Market Restraint Estimates
220.127.116.11. Lesser Rate of Reimbursement
18.104.22.168. Stringent Regulatory Background
3.4. Market Estimates – Porter’s
3.5. Latin America IVD Market PESTEL Estimates, 2015
Chapter 4. Latin America IVD Product Outlook
4.1. Latin America IVD Market Share by Product, 2015 & 2024
4.2.1. Instruments Market Estimates and Forecasts, 2013 – 2024
4.3.1. Reagents Market Estimates and Forecasts, 2013 – 2024
4.4.1. Software Market Estimates and Forecasts, 2013 – 2024
Chapter 5. Latin America IVD Technology Outlook
5.1. Latin America IVD Market Share by technology, 2015 & 2024
5.2.1. Immunochemistry Market Estimates and Forecasts, 2013 – 2024
5.3.1. Hematology Market Estimates and Forecasts, 2013 – 2024
5.4. Clinical Chemistry
5.4.1. Clinical Chemistry Market Estimates and Forecasts, 2013 – 2024
5.5. Molecular Diagnostics
5.5.1. Molecular Diagnostics Market Estimates and Forecasts, 2013 – 2024
5.6.1. Coagulation Market Estimates and Forecasts, 2013 – 2024
5.7.1. Microbiology Market Estimates and Forecasts, 2013 – 2024
5.8. Other Clinical Technology
5.8.1. Other Clinical Technology Market Estimates and Forecasts, 2013 – 2024
Buy a Sample Copy of This Report @ http://www.radiantinsights.com/research/latin-america-in-vitro-diagnostics-ivd-market/request-sample
Radiant Insights Inc. is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Company Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist – USA
Phone: (415) 349-0054, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
Country: United States